Pharmadelic Labs is a biotech company focusing on improving and patenting engineering processes for the biosynthesis of compounds - primarily psilocybin, the psychoactive component of magic mushrooms.

With the anticipated global demand for psilocybin about to increase rapidly, Pharmadelic Labs is improving biosynthesis pathways to create psilocybin more quickly, cheaply and consistently than traditional greenhouse methods. These pathways will allow pharmaceutical-grade psilocybin to be grown in days as opposed to weeks.

Led by an experienced team, Pharmadelic Labs is already set up in its laboratory in Victoria, British Columbia.